These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29726125)

  • 1. Long-term oncological outcomes of local excision versus radical resection for early colorectal cancer in young patients without preoperative chemoradiotherapy: a population-based propensity matching study.
    Cao B; Min L; Zhu S; Shi H; Zhang S
    Cancer Med; 2018 Jun; 7(6):2415-2422. PubMed ID: 29726125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
    Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
    Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local resection versus radical resection after neoadjuvant chemoradiotherapy for patients with locally advanced rectal cancer: a propensity-score matched cohort analysis.
    Wang G; Yao K; Yang Y; Chen H; Tang Z; Ye J; Fu M; Xue X; Shen Q; Tang H; Guo Y; Huang Y
    BMC Gastroenterol; 2023 Jun; 23(1):205. PubMed ID: 37312044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Chen Q; Chen J; Huang Z; Zhao H; Cai J
    Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.
    Ishihara S; Kanemitsu Y; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2016 Jul; 31(7):1315-21. PubMed ID: 27240821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
    Yang KM; Lim SB; Lee JL; Kim CW; Yoon YS; Park IJ; Yu CS; Kim JC
    Int J Colorectal Dis; 2018 Apr; 33(4):487-491. PubMed ID: 29468352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
    Shin YS; Park JH; Yoon SM; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Choi EK; Ahn SD; Lee SW; Kim JH
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):630-639. PubMed ID: 29678529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based assessment of the surgical management of locally advanced colorectal cancer.
    Govindarajan A; Coburn NG; Kiss A; Rabeneck L; Smith AJ; Law CH
    J Natl Cancer Inst; 2006 Oct; 98(20):1474-81. PubMed ID: 17047196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
    Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis following surgical resection versus local excision of stage pT1 colorectal cancer: A population-based cohort study.
    McBride R; Hicks BM; Coleman HG; Loughrey MB; Gavin AT; Dunne PD; Campbell WJ
    Surgeon; 2020 Apr; 18(2):65-74. PubMed ID: 31402122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prognostic in different age groups of patients undergoing local versus radical excision for rectal cancer: a study based on the SEER database.
    Li J; Wen L; Ma Y; Zhang G; Wang P; Huang C; Yao X
    Updates Surg; 2024 Jun; 76(3):975-988. PubMed ID: 38704811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic Resection is a Good Prognostic Factor in Rectal Cancer Compared with Laparoscopic Resection: Long-term Survival Analysis Using Propensity Score Matching.
    Kim J; Baek SJ; Kang DW; Roh YE; Lee JW; Kwak HD; Kwak JM; Kim SH
    Dis Colon Rectum; 2017 Mar; 60(3):266-273. PubMed ID: 28177988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of locally or radically resected T1 colorectal cancer.
    Nam MJ; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Kim SY; Baek JY; Park SC; Oh JH
    Colorectal Dis; 2016 Sep; 18(9):852-60. PubMed ID: 26589573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis.
    Kim Y; Kim DY; Kim TH; Kim SY; Baek JY; Kim MJ; Chang HJ; Cha Y; Park SC; Oh JH
    Br J Radiol; 2018 Dec; 91(1092):20180143. PubMed ID: 30129789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.